Impact of delisting melatonin from a health-system formulary on psychotropic utilization
{{output}}
ObjectiveTo characterize the trends of psychotropic utilization before and after the formulary removal of melatonin in Alberta, Canada.MethodsWe conducted a retrospective drug utilization review of patients admitted to inpatient, long-term care, and pediatric ... ...
